The FDA this week issued updates on several drugs that are currently in shortage or have been discontinued:
- Amino Acids (Updated – Currently in Shortage)
- Belladonna and Opium Suppository (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Cefepime Injection (Updated – Currently in Shortage)
- Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)
- Etoposide Injection (Updated – Currently in Shortage)
- Fluorescein Injection (New – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
- Leuprolide Acetate Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Magnesium Sulfate Injection (Updated – Currently in Shortage)
- Meperidine Hydrochloride Injection, USP, CII (New – Discontinuation)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Norethindrone and Ethinyl Estradiol Tablets (New – Discontinuation)
- Norethindrone Tablets (New – Discontinuation)
- Olmesartan Medoxomil and Hydrochlorothiazide Tablets (New – Discontinuation)
- Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (Updated – Currently in Shortage)
- Ropivacaine Hydrochloride injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials (New – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
